Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 18.9 TWD -0.79% Market Closed
Market Cap: NT$8.1B

Adimmune Corp
Investor Relations

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Show more
Loading
4142
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Chi-Hsien Chan
CEO & Chairman
No Bio Available
Mr. Chung-Cheng Liu
President, GM & Director
No Bio Available
Mr. Chin-Chuan Chang
COO and VP of R&D
No Bio Available
Mr. Fei Pan
Chief Legal Officer & General Counsel
No Bio Available
Dr. Chun Cheng Chen M.B.A., M.D., M.Sc., Ph.D.
Chief Medical Officer
No Bio Available
Mr. Yin-Teng Chang
Chief Financial Officer
No Bio Available
Ms. Li-Ya Tang
Director of Administration Center
No Bio Available
Chih-Hsiang Leng
Head of R&D Division
No Bio Available
Mr. Chin-I Chiu
Vice President of Quality Assurance Department
No Bio Available

Contacts

Address
TAICHUNG
TAICHUNG
No.3, Section 1, Tanxing Road, Tanzi District
Contacts
+886425381220
www.adimmune.com.tw